Islet Cell Transplant: Successful Survival Through two Pregnancies

ABSTRACT: Objective: To review the clinical course of a woman who, after islet cell transplant, successfully carried 2 pregnancies to term.Methods: Clinical and laboratory data are presented.Results: This is the first report of a woman with type 1 diabetes mellitus who received an islet cell transpl...

Full description

Bibliographic Details
Main Authors: Angela L. Magdaleno, DO, Marc A. Vengrove, DO, FACP
Format: Article
Language:English
Published: Elsevier 2018-03-01
Series:AACE Clinical Case Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2376060520304715
id doaj-88fcaaa2f71146bd8933e567a8a7164a
record_format Article
spelling doaj-88fcaaa2f71146bd8933e567a8a7164a2021-04-30T07:24:49ZengElsevierAACE Clinical Case Reports2376-06052018-03-0142124126Islet Cell Transplant: Successful Survival Through two PregnanciesAngela L. Magdaleno, DO0Marc A. Vengrove, DO, FACP1From the Department of Internal Medicine, Lehigh Valley Health Network, Allentown, PennsylvaniaDepartment of Internal Medicine, Division of Endocrinology, Lehigh Valley Health Network, Allentown, Pennsylvania.; Address correspondence to Dr. Marc A. Vengrove, LVPG Diabetes and Endocrinology, 1243 South Cedar Crest Boulevard, Suite 2800, Allentown, PA 18103.ABSTRACT: Objective: To review the clinical course of a woman who, after islet cell transplant, successfully carried 2 pregnancies to term.Methods: Clinical and laboratory data are presented.Results: This is the first report of a woman with type 1 diabetes mellitus who received an islet cell transplant and then successfully carried 2 pregnancies to term. Hemoglobin A1c levels were within the goal range for both pregnancies. Only the administration of basal insulin was required with each pregnancy. Basal insulin requirements increased from the first to second pregnancy (from 0.42 U/kg to 0.70 U/kg). There were no major congenital malformations, macrosomia, or neonatal hypoglycemia.Conclusion: Excellent glycemic control was maintained with basal insulin therapy during both pregnancies. The significance of the increased basal insulin requirements during the second pregnancy in regards to islet cell function and future islet cell viability is currently unknown.Abbreviations: DM1 type 1 diabetes mellitus HbA1c hemoglobin A1chttp://www.sciencedirect.com/science/article/pii/S2376060520304715
collection DOAJ
language English
format Article
sources DOAJ
author Angela L. Magdaleno, DO
Marc A. Vengrove, DO, FACP
spellingShingle Angela L. Magdaleno, DO
Marc A. Vengrove, DO, FACP
Islet Cell Transplant: Successful Survival Through two Pregnancies
AACE Clinical Case Reports
author_facet Angela L. Magdaleno, DO
Marc A. Vengrove, DO, FACP
author_sort Angela L. Magdaleno, DO
title Islet Cell Transplant: Successful Survival Through two Pregnancies
title_short Islet Cell Transplant: Successful Survival Through two Pregnancies
title_full Islet Cell Transplant: Successful Survival Through two Pregnancies
title_fullStr Islet Cell Transplant: Successful Survival Through two Pregnancies
title_full_unstemmed Islet Cell Transplant: Successful Survival Through two Pregnancies
title_sort islet cell transplant: successful survival through two pregnancies
publisher Elsevier
series AACE Clinical Case Reports
issn 2376-0605
publishDate 2018-03-01
description ABSTRACT: Objective: To review the clinical course of a woman who, after islet cell transplant, successfully carried 2 pregnancies to term.Methods: Clinical and laboratory data are presented.Results: This is the first report of a woman with type 1 diabetes mellitus who received an islet cell transplant and then successfully carried 2 pregnancies to term. Hemoglobin A1c levels were within the goal range for both pregnancies. Only the administration of basal insulin was required with each pregnancy. Basal insulin requirements increased from the first to second pregnancy (from 0.42 U/kg to 0.70 U/kg). There were no major congenital malformations, macrosomia, or neonatal hypoglycemia.Conclusion: Excellent glycemic control was maintained with basal insulin therapy during both pregnancies. The significance of the increased basal insulin requirements during the second pregnancy in regards to islet cell function and future islet cell viability is currently unknown.Abbreviations: DM1 type 1 diabetes mellitus HbA1c hemoglobin A1c
url http://www.sciencedirect.com/science/article/pii/S2376060520304715
work_keys_str_mv AT angelalmagdalenodo isletcelltransplantsuccessfulsurvivalthroughtwopregnancies
AT marcavengrovedofacp isletcelltransplantsuccessfulsurvivalthroughtwopregnancies
_version_ 1721498401593360384